Maria T Acosta MD
Pediatric Neurologist, Staff Clinician. Gene Therapy Program - GM1 - Undiagnosed Disease Program. National Human Genome Research Institute. National Institute of Health. Bethesda, MD USA
Join to View Full Profile
Clinical Center Building 10 9C-440Bethesda, MD 20892
Phone+1 301-503-3220
Dr. Acosta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's National HospitalResidency, Pediatrics, 2003 - 2004- Children's National Hospital/George Washington UniversityFellowship, Child Neurology, 2000 - 2003
Industrial University of Santander Faculty of MedicineClass of 1987
Certifications & Licensure
DC State Medical License 2005 - 2026
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- 1 citationsPsychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments.Belinda Barton, Pamela L Wolters, Karin S Walsh, Nicole J Ullrich, Tena Rosser
Journal of Neuro-Oncology. 2025-08-01 - 6 citationsComputerized Working Memory Training for Children With Neurofibromatosis Type 1 (NF1): A Pilot Study.Kristina K. Hardy, Carly Berger, Danielle Griffin, Karin S. Walsh, Christina M. Sharkey
Journal of Child Neurology. 2021-09-02 - 7 citationsOne is the loneliest number: genotypic matchmaking using the electronic health record.Elly Brokamp, Mary Koziura, John A. Phillips, Leigh Anne Tang, Joy D. Cogan
Genetics in Medicine. 2021-07-06
Journal Articles
- Germline and Somatic NF1 Alterations Are Linked to Increased HER2 Expression in Breast CancerMaria T Acosta, Bruce R Korf, Clinical Cancer Research
Press Mentions
Common Cholesterol Drug Safe, May Improve Learning Disabilities in Patients with Neurofibromatosis, Study FindsSeptember 27th, 2011
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
